Kidney perfusion fluid may hold clues to transplant quality

NCT ID NCT03024229

Completed Knowledge-focused Sponsor: University Hospital, Tours Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether analyzing the fluid used to preserve kidneys on a LifePort® machine could help predict how well the kidney will work after transplant. Researchers measured chemicals in the fluid and compared them to early kidney function in 40 recipients. The goal is to find a better way to assess organ quality before surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a new way to assess kidney quality before transplant, potentially reducing the risk of delayed function.
What could go wrong: This is a small, completed observational study with only 40 participants. The findings may not apply to all transplant centers or improve actual outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RENAL TRANSPLANTATION

Contacts and locations

Locations

CHR-ORLEANS Service d'Urologie

Orléans, Loiret, 45100, France
Urology CHRU-TOURS

Tours, I&L, 37000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.